At a glance
- Originator Nippon Kayaku
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 16 Nov 1995 Discontinued-Preclinical for Candidiasis in Japan (Unknown route)
- 27 Jul 1995 New profile
- 27 Jul 1995 Preclinical development for Candidiasis in Japan (Intraperitoneal)